Abstract
Human respiratory syncytial virus (RSV) is an important pathogen responsible for bronchitis and pneumonia in young children.No safe and effective vaccines are available so far.Great progress has been made in molecular biology,epidemiology,and pathogenic mechanism of RSV during the past several decades.In this paper,virological and epidemiological characteristics,and vaccine development strategies of RSV are reviewed. Key words: Respiratory syncytial virus,human ; Respiratory syncytial virus vaccines ; Epidemiology ;
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
